J Clin Invest. 1986;78(3):784-789. https://doi.org/10.1172/JCI112641. B cell hyperactivity and resistance to tolerance induction are well-recognized immunologic abnormalities associated with both human and murine models of systemic lupus erythematosus. Studies evaluating the role of B cells in these defects have been complicated by the difficulties of consistently isolating large numbers of B cells from T cells and other host-derived regulatory factors. We have recently developed continuous cell lines of B lymphocytes with a high degree of specificity for the antigen dinitrophenyl (DNP) from both New Zealand black times New Zealand white F1 hybrid (BWF1) and BALB/c mice, and we used them to study intrinsic B cell defects in autoimmunity. We found that the kinetics of the immune response to the antigen DNP-Ficoll of both the BWF1 and BALB/c B cell lines are not different. In addition, the BWF1 cell lines, like the BALB/c cell lines and normal B cells, require nonspecific T cell-derived factors as well as antigen to produce an immune response. Tolerance was tested in the BWF1 B cells by preincubating them with DNP-murine IgG2a (MGG), which can induce tolerance in BALB/c cell line lymphocytes. The BWF1 B cell lines were resistant to tolerance induction by DNP-MGG and required 50fold higher dose of DNP-MGG than BALB/c cell lines for suppression. They were also relatively resistant to tolerance with trinitrophenyl-d-glutamyl lysine. Thus, DNP-specific B
Introduction
Our understanding of the immunologic defects associated with systemic lupus erythematosus has been greatly advanced by the use ofseveral murine strains that develop an autoimmune disease very similar to systemic lupus erythematosus. Using these inbred strains of mice, several investigators have studied the phenomenon ofimmunologic tolerance in an attempt to pinpoint specific cellular defects associated with this autoimmune state (1) (2) (3) (4) (5) . Most ofthese investigators have found that in general there is a relative resistance to tolerance induction in several strains of autoimmune mice. Several studies have attempted to determine whether this tolerance resistance is due to a defect in the B cell or in regulatory T cells. However, the results have been conflicting. (2, 3) . Studies of specific cellular defects have been hindered by the difficulty in obtaining model systems in which large numbers of antigen-specific B cells can be isolated from other host cells and T cell-derived factors. Even in vitro studies in which T cell-depleted splenic lymphocytes were used cannot consistently avoid small amounts of T cell contamination (4) . In addition, these splenic B cells have matured in vivo under the influence of possibly abnormal host cells and T cell-derived factors, and this influence may last for several days after the cells are isolated in vitro (5) . To overcome these difficulties we have developed continuous pure B cell lines from NZB times New Zealand white (NZW) F, hybrid mice (BWF,) that have a significant proportion of cells that are specific for the hapten dinitrophenyl (DNP). These cells have been maintained in tissue culture for more than one year. These cell lines have no T cell or macrophage contamination and they are no different than previously described BALB/c cell lines (6) in terms of spontaneous [3H]thymidine and [3H]uridine uptake in the unstimulated state (7) . These cells can be used as a model system for studying intrinsic B cell abnormalities in autoimmune mice.
The present studies make use of these DNP-specific B cell lines from both autoimmune BWF, and normal BALB/c mice to compare the antigen-specific immune response and tolerance induction between the BWFI and BALB/c cell lines. We found that the requirement of the BWF, cell lines for nonspecific T cell factors in order to produce an immune response after stimulation with specific antigen was the same as that noted for BALB/c mice. We also found that the kinetics of the anti-DNP response to DNP-Ficoll was the same for normal and autoimmune cell lines. To investigate antigen-specific tolerance in the cells from autoimmune mice we used the system of tolerance induction in which the hapten DNP is bound to mouse IgGu (DNP-MGG). DNP-MGG has been previously shown to induce tolerance in both normal splenic B lymphocytes and in cell line B lymphocytes from normal BALB/c mice (8, 9) . We The Jackson Laboratory, Bar Harbor, ME, and used to develop the cell lines. T cell-derived growth and differentiation factors. EL4 lymphoma cells were passaged by intraperitoneal injection into C57BL/6 mice. The cells were harvested from the peritoneum. 2 X 106/ml sterile ELT cells were then grown in culture for 24 h in serum-free RPMI medium supplemented with penicillin, streptomycin, and 10 ng/ml of phorbol myristate acetate (PMA), washed thoroughly to remove the PMA, and placed back in RPMI medium. The supernatant was collected after 48 h of further growth without PMA and stored in aliquots at -70'C. This EL-4 supernatant has been previously shown to be required for both continuous growth of the cell lines and for an immune response in DNP-Ficoll-stimulated cell line lymphocytes (6, 10) .
DNP-specific B cell lines. B lymphocyte lines from normal BALB/c 8-12-wk-old female mice were isolated and propagated as previously described (6) . The characteristics of these BALB/c cell lines have been described elsewhere. (11) Briefly, the cell lines are nonmalignant and not transformed and are propogated in the absence of antigen. They have resting B cells as well as some B cells in the activated state, and thus are similar to splenic B cells, as described by Thompson et al. (11, 12) . Similar continuous B cell lines were isolated from autoimmune BWF1 mice and propagated as described for BALB/c mice (7) (manuscript in preparation). Briefly, splenic lymphocytes from 8-wk-old female BWF1 mice were enriched for DNP-specific B cells by the method of Haas and Layton (13) . The enriched cells were cloned in soft agar by a modification of the method of Pillai and Scott (14) . After 24 h incubation the cells were layered over with complete Dulbecco's modified Eagle's medium (DME) with 20% ETA supernatant. As the colonies became macroscopic they were picked from the agar with the aid of a dissecting microscope and placed in individual wells of a 96-well culture plate (Falcon Labware, Div. of Becton-Dickinson & Co., Oxnard, CA). When cells had grown to confluency they were transferred to 24-cm tissue culture flasks.
These cells are pure B cell lines with no macrophage or T cell contamination (6, 7) (manuscript in preparation). The cell lines are maintained in DME supplemented with 100 U/ml penicillin, 100 ug/ml streptomycin, 5 X 10-1 M 2-mercaptoethanol, 0.1 mM nonessential amino acids, 100 mM L-glutamine, and 10% fetal calf serum (HyClone Sterile Systems, Inc., Logan, UT). 20% ELA supernatant was required for the continued growth of these cell lines in culture. The medium was changed twice weekly and the cultures split when they became confluent. There is no antigen or lipopolysaccharide present in the medium.
Antigen stimulation ofcell line lymphocytes. 101 cell line lymphocytes from either the BALB/c or the BWF1 cell lines were placed in individual wells of a 96-well microculture plate. DNP-Ficoll (20 ng/ml) was added to each well ofthe antigen-stimulated groups and the volume of the well was brought up to 250 ul using complete DME. Except where indicated in results, 20% EL-4 supernatant and 10' freshly obtained normal rat thymus cells that had been irradiated with 2,000 rad 1-2 h before culture were added to each well. Background response was determined by culturing line cells with ET4 supernatant and filler cells without antigen. h of preincubation with DNP-MGG, the cell line lymphocytes were washed three times to remove all tolerogen and placed back in culture with 20 ng/ml of the antigen DNP-Ficoll plus I0O rat thymus filler cells irradiated with 2,000 rad. After 4 d in culture the antibody-forming cells were assayed as noted above. 20% EL-4 supernatant was also present during preincubation with tolerogen. Cultures preincubated in medium without tolerogen and then cultured with DNP-Ficoll were used as immune controls. Cultures incubated without either tolerogen or DNP-Ficoll were used as background controls.
In some experiments cells were grown for 30 d in the presence of DNP-MGG. Controls were treated in the same fashion but did not have DNP-MGG in the medium. At the end of this 30-d period the cells were washed free oftolerogen and placed back in culture. At varying numbers of days after removal of DNP-MGG, aliquots of cells from control or DNP-MGG groups were cultured with antigen in the presence of filler cells and EL-4 supernatant, and the PFC response assayed 5 d later.
Hapten-protein conjugates. 2,4-Dinitrobenzene sulfonic acid was twice recrystalized according to the method of Eisen and bound to murine IgG2. as previously described (16) . Murine IgG2. was separated from the ascites of mice bearing the plasmacytoma RPC5 by starch block electrophoresis as previously described (17) . DNP-Ficoll was obtained from Biosearch, San Rafael, CA. TNP7 dGL was the generous gift of Dr. Eliot Goldings (University of Texas Health Science Center at Dallas, TX). TNP27 dGL and TNP116 dGL were made by conjugating TNP to the dGL polymer by the method of Goldings and Mosier (18) .
Viability assay. I05 cell line lymphocytes were incubated for 24 h in DME with 20% EL-4 growth factors and varying concentrations ofDNP-MGG. The cells were then tested for viability by trypan blue dye exclusion.
Statistics. Values expressed are the means±standard errors of 3-4 separate cultures. Each experiment was performed 2-3 times to document reproducibility of data. In most cases only data from one representative experiment is shown. Groups were statistically compared using a onetailed Student's t test.
Results
Previous results in our laboratory have shown that the nonautoimmune BALB/c cell lines require filler cells and nonspecific T cell-derived factors to produce an immune response upon stimulation with DNP-Ficoll (1 1). This requirement for soluble T cell-derived factors for antibody production to occur after stimulation with T-independent antigen is similar to that found in normal B cells (18) (19) (20) . The possibility was raised that such a requirement may be absent in the BWF1 cell lines, since these mice have an increased number ofB cells spontaneously secreting antibody and their B cells have been shown to be hyperactive in vivo (21) . To test this we cultured BWF1 cell line lymphocytes with 20 ng/ml of DNP-Ficoll both with and without EL-4 supernatant and irradiated normal rat thymus filler cells. The BWF1 B cell lines show no increase over background in antibodyforming cells after stimulation with DNP-Ficoll in the absence ofEL-4 supernatant and filler cells (Fig. 1 ). However, a significant immune response occurs when these cell line lymphocytes are stimulated with DNP-Ficoll in the presence of these factors (P <0.05).
The kinetics of the immune response in these cell line lymphocytes was measured at various times after stimulation ofthe cells with DNP-Ficoll in the presence of EL-4 supernatant and filler cells. The peak response of the BWF, cells occurs at 4-5 d after antigen-specific activation, and there is a return to background levels of antibody-forming cells by 8 d after stimulation with all three. Only the cell line cultures that contained all three constituents demonstrated a significant PFC response (P < 0.05).
( Fig. 2, A and B) . This response is similar to that found for the BALB/c cell line lymphocytes and is also similar to that found in freshly obtained splenic lymphocytes from BALB/c mice. To study the phenomena of antigen-specific tolerance we used DNP-MGG as a tolerogen because, in previous studies, we have shown that preincubation of BALB/c cell lines for 48 h with DNP-MGG renders them tolerant to further stimulation with DNP-Ficoll (9) . This tolerance in BALB/c cell line lymphocytes is antigen specific, occurs with or without nonspecific T cell factors present in the preincubation period, and occurs at a concentration of 10-200 ,ug/ml of DtP-MGG (9) . To test whether there was a tolerance defect inherent in the BWF1 B cells, cells from both the BALB/c and the BWF, cell lines were preincubated for 48 h with 200 ;tg/ml DNP-MGG, washed free of tolerogen and then cultured with DNP-Ficoll, filler cells and EL-4 supernatant for 4 d, washed, and assayed for PFC. Appropriate immune and background controls were set up as described for each cell line. There was a statistically significant suppression (P < 0.05) of the BALB/c cells preincubated with DNP-MGG when compared with the immune controls ( Fig. 3) . However, BWF1 cell lines preincubated with DNP-MGG were not significantly suppressed compared with control BWFI cells. Similar experiments with three other BWF1 cell lines and three BALB/ c lines gave identical results (data not shown).
KINECTICS OF THE IMMUNE RESPONSE
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Goldings has shown that in B lymphocytes isolated from spleens of BWFI mice, resistance to tolerance induction is partially dependent upon the epitope density of the antigen carrier complex (3). To test whether a similar dependence on the epitope density ofDNP-MGG was involved in the resistance to tolerance seen here, the experiments were repeated using DNP26 MGG and DNP12 MGG. Tolerance in the BWF1 cells was not induced at either epitope density (Fig. 4 ). Since it is known that DNP-MGG at epitope densities above 30 will not induce tolerance in nonautoimmune lymphocytes, we did not test DNP-MGG with a very high substitution ratio (22) .
The BWFI cell line lymphocytes were preincubated with DNP-MGG at various concentrations ranging from 200 to 1,000 ,g/ml. As before, the BWF1 cells preincubated with 200 Asg/ml DNP-MGG showed no statistically significant difference in their response to stimulation with DNP-Ficoll. However, there was a significant difference in the PFC response of those cells preincubated with DNP-MGG at concentrations of 500 and 1,000 ,g/ml (Fig. 5) . A cytotoxicity assay using trypan blue exclusion showed that incubation of the cells with 500 gg/ml of DNP-MGG produced no significant cell death, but a mild degree of cytotoxicity was found in some cell lines when tested with 1,000 Atg/ml DNP-MGG. Thus, at least 500 ,ug/ml DNP-MGG is needed to induce tolerance in BWF, B cells, which indicates that BWF, B cell lines have a 50-fold difference in sensitivity to tolerance induction with DNP-MGG when compared with the BALB/c cell lines. Similar studies were done using the tolerogen TNP-dGL, which induces B cell tolerance without affecting Fc receptors. TNP-dGL (100 jg/ml) of varying epitope densities was used in each 48-h preincubation. The results (Fig. 6) show that TNP7 dGL did not induce tolerance in either BALB/c or BWF1 cell lines. TNP27 dGL induced tolerance in nonautoimmune BALB/ c cell lines (P < 0.05) but not in the BWF1 cell lines, while TNP133 dGL induced tolerance in both BWF1 and BALB/c cell line lymphocytes.
We have previously shown that BALB/c cell lines can grow in the presence of DNP-MGG, and become tolerant. This tolerance has many characteristics that are predicted for the theoretical clonal anergy (23, 24 ). Thus, we tested whether B cell lines from autoimmune mice can grow in the presence of DNP-MGG, and whether they become tolerant. Several cell lines were propagated in the presence of 200 ,g/ml DNP-MGG and tested for tolerance as described in Methods. The BWF, and BALB/c cell lines were tolerant at the end of 30 d (Fig. 7) . Like the BALB/c cell lines, the BWF, cell lines lost tolerance soon after removal of DNP-MGG. CELL 
Discussion
The availability of pure B cell lines that have been outside of the host regulatory influence for a period of time allows us to explore possible defects of B cell response that may be intrinsic to the B cell itself. Although these B cell lines are not entirely "normal" due to their prolonged in vitro growth, they are nonmalignant and have many characteristics that are similar to normal splenic B cells (11) . Since the BWF, cell lines are being compared with nonautoimmune BALB/c cell lines, any abnormalities ofthe cells that could be due to prolonged in vitro growth would be controlled, since they should also exist in BALB/c lines. Tolerance induction in these cell lines is similar to that seen in splenic B cells in vitro: it is antigen specific, dose dependent, and not associated with cell death (11) . Thus, this is a suitable model for the study of the tolerance defect in the BWF1 B cell. These studies indicate that the BWF, B cell line lymphocytes are no different than the normal BALB/c cell lines or normal spleen cells in the kinetics of the immune response produced by antigen-specific stimulation with DNP-Ficoll. These BWF1 cell lines are also similar to BALB/c cells in their requirement for filler cells and nonspecific T cell-derived factors to produce an immune response upon antigen stimulation. These studies do not address the question ofwhether autoimmune B cell lines produce more antibody or greater numbers of PFC after stimulation, nor do they rule out the possibility that the cells may require significantly lower concentrations of T cell-derived factors to initiate and sustain an immune response. These questions are being addressed in other studies. However, we have demonstrated that B cells from BWF1 mice do have a resistance to tolerance that is intrinsic and not dependent on T cells.
Our studies do not rule out the possibility that there is a concomitant defect in the T cells themselves or in the T cellderived growth factors that may also play a role in the abnormal antigen-specific tolerance seen in BWF1 mice. Nor can these experiments be extrapolated to tolerance of nucleoside or DNA antigens or to other strains of autoimmune mice. Most of the studies showing tolerance defects have used heterologous antigens, and indeed this study also uses the heterologous determinant DNP. However, Lewis et al. was able to induce tolerance to the self antigen, nucleosides, in BWF1 mice (25) . Thus, these studies do not address mechanisms of self-tolerance directly. However, we now have the ability using these same methods to study antigen-specific tolerance in other mouse strains, and with self-antigenic determinants that may be more pertinent to the autoimmune process.
The resistance to tolerance in the BWF1 B cell is not absolute, but is due to a decrease in sensitivity of the cell to tolerance induction. Tolerance to DNP-MGG requires 50 times more tolerogen than needed for BALB/c B cells. TNP-dGL requires fivefold increase in the density of hapten on carrier. Goldings has previously shown that the tolerance defect in NZB mice in vivo is not seen with high hapten carrier ratios (3). Thus, these in vitro studies are in agreement with previous in vivo data. The exact defect responsible for the resistance to tolerance induction seen in the BWF1 cell lines is not yet clearly understood. There are a number ofpossible explanations for this. It is unlikely that Fc receptors play a role, since there is also resistance to tolerance with TNP-dGL. Perhaps there are fewer receptors by which the DNP-MGG initiates tolerance. Alternatively, the receptor affinity for DNP-MGG may be lower than that on the normal B cells. That higher doses of DNP-MGG and higher epitope density of TNP-dGL can induce tolerance is compatible with these possibilities. However, it may also be possible that the receptors themselves are normal, but the biochemical events that follow receptor tolerogen interaction are abnormal. It is obvious that further studies are required to determine what changes occur in these cells once they are exposed to tolerogen and what differences there are in these changes between the B cell lines from normal and autoimmune mice.
There is a great deal of evidence that propagating the B cell lines in the presence of DNP-MGG is a model of clonal anergy (23, 24) . B cells grown in the presence of DNP-MGG grow at the same rate as controls and continue to develop and express surface receptors to the same extent as controls, but they become unresponsive to antigen. That BWF1 cells grown in DNP-MGG also become unresponsive to the same extent as controls suggests that immature B cells from this strain are not as resistant to tolerance as the mature B cells. An alternative explanation is that longer exposure of mature cells to the tolerogen may allow tolerance induction. These alternatives are being explored. However, our findings of normal tolerance induction in immature BWF1 B cells and defects in tolerance induction in mature B cells are compatible with the course of events in the BWF, mouse, in which the animal is tolerant to self after birth but acquires autoimmunity as it gets older.
